Betr GLP-1 Step Therapy Program Achieves Sustainable Member Results at a Fraction of the Cost
The Problem
Employers and payers are experiencing skyrocketing demand for GLP-1s. The financial burden of covering GLP-1s are substantial and many are seeing their Rx cost triple in less than a year. In 2022, five million GLP-1 prescriptions were written representing a 2082% increase from 2019.
As a result, many plan sponsors are implementing prior authorizations and employers are requiring employees who quality for obesity care to utilize “step therapy” – whereby a patient must first start with a cheaper drug before switching to a higher cost alternative.
A Novel Step Therapy Approach for GLP-1s
Instead of starting patients on a cheaper drug first, an alternative step therapy model to consider is bypassing drugs all together. This model works by providing the one thing that every human being needs: Food as Medicine. With Food as Medicine as the first line of treatment, employers and payers can:
- Support end users in adopting sustainable behavior and lifestyle change with a comprehensive and personalized approach
- Educate end users on the risks associated with GLP-1s
- Empower end users to avoid, reduce or eliminate GLP-1s completely
An Affordable and Sustainable Care Method
Food as Medicine as a first line of treatment is a faster and less expensive solution when compared to the leading GLP-1s. Based on historical data, Betr members reach medically significant weight loss faster and more sustainably than one of the best-selling weight loss drugs on the market.
Outcomes in half the time at a fraction of the cost
12.5% Weight Loss
- Betr: 16 weeks
- A leading GLP-1: 32 weeks
Cost
- Betr: $3,000 over 52 weeks
- A leading GLP-1: $16,800 over 52 weeks
Easy to Implement
Betr’s GLP-1 Step Therapy program is available to payers and employers and can be live in less than 30 days.